![]() ![]() As part of this effort, RADx Tech engaged several different groups, including the Georgia Tech HomeLab, to conduct test accessibility evaluations advocacy group partners to onboard accessibility design consultants from the target user populations and academic centers specializing in accessibility to onboard additional subject matter experts (SMEs). NIH RADx Tech established a formal funding opportunity for accessible COVID-19 home tests. Importantly, these advocacy groups include members of the populations they serve. Consequently, the team engaged advocacy groups with a deep knowledge of the experience and needs of target user populations. Comprehensive guidelines for manufacturers around accessible design of in vitro diagnostic (IVD) products were nonexistent. As a first step, the team consulted design groups and conducted research to locate existing accessible product design guidelines. NIH RADx Tech began committing resources to increasing accessibility of COVID-19 home tests in early 2022. ![]() While NIH RADx Tech has increased testing capacity in the U.S., there is a continuing need to develop COVID-19 home tests that are accessible to all users, including populations that have no vision or low vision, have a reduced range of dexterity or motor skills, and are aging. The RADx Tech program, one arm of the initiative, was specifically designed to compress the customary technology development timeline from years down to just months. In response to the COVID-19 pandemic, the National Institutes of Health (NIH) launched the Rapid Acceleration of Diagnostics (RADx®) initiative in 2020 to speed the innovation, development, commercialization, and implementation of COVID-19 testing technologies. Food and Drug Administration, National Center for Medical Rehabilitation Research, National Council on Disability, National Eye Institute, National Institute of Dental and Craniofacial Research, National Institute of Nursing Research, National Institute on Disability, Independent Living, Rehabilitation Research within the Administration for Community Living. National Institute of Biomedical Imaging and Bioengineering:Ĭhristine Cooper, Karen Olsen, Patricia Wiley.Ĭenters for Disease Control and Prevention, U.S. Bradley Fain, Sarah Farmer, Adina Martinez, Amanda Peagler, Rebecca Sheiner.Īlliance on Aging and Vision Loss, American Council of the Blind, American Foundation for the Blind, American Geriatrics Society, Independence Through Enhancement of Medicare and Medicaid Coalition, National Disability Rights Network, National Federation of the Blind, World Institute on Disability.īruce Bailey, Phil Bratta, Bobby Stinnette. ![]() Danial, Praveen Prabhakar KR, Angie Reitenbach, Bryce G. Victoria Brown, Emma DeRoode, Nicole Lee, Susan McDonald, Becky Nelson. Bern Jordan, Jason Meddaugh, Corbb O’Connor, Helen Osborne, Ellen Ringlein, Romina Marazzato Sparano, Gregg Vanderheiden, Genevieve Walker, Lindsay Yazzolino, Kennedy Zimnik. Jackie Anderson, Karl Belanger, Samantha Flax, Chancey Fleet, J. Kennedy, Kevin Leite, Shaun Moshasha, Kim Noble, Clair O’Donovan, D’lynne Plummer, Adam Samuta, Mack Schermer, Sal Strods, Erika Tyburski, Brian Walsh.Ĭonsortia for Improving Medicine with Innovation and Technology: John Blackwood, Cathy Cambria, Mia Cirrincione, Jim Densmore, Sam Dolphin, Maren Downing, Emily B. Rapid Acceleration of Diagnostics (RADx®) Tech Program: We would like to acknowledge the efforts of all of those involved in the development of these best practices: Best Practices for the Design of Accessible COVID-19 Home Tests ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |